>
 
 

Investment Funds

Central & Eastern European Funds
Latin American Funds
Asian Funds

Other European Funds

Caresbac Polska
Baltics Small Equity Fund
SEAF Macedonia
Central/Eastern European Fund
Trans-Balkan Bulgaria Fund
Trans-Balkan Romania Fund
SEAF Croatia
SEAF South Balkan Fund
Georgia Regional Development Fund

Central/Eastern European Growth Fund

Headquarters: 

Raua 20-5
Tallinn 10152, Estonia
Tel: (372) 534 49542
E-mail: bsef@bsef.ee

Website: www.bsef.ee
Year Established: 2000
Fund Size: USD 20,600,000
Investors: Deutsche Investions- und Entwicklungsgesellschaft (DEG), State Secretariat for Economic Affairs (SECO), International Finance Corporation (IFC), Finnish Fund Industrial Co-operation (FinnFund), Evangelische Kirche, Merifin, SEAF and Calvert
Investment Focus By Stage: Early stage and expansion of SMEs
Investment Focus by Geography: Central and Eastern Europe
Investment Size: USD 500,000-4,000,0000 per Portfolio Company
Director General: Gary Dodge

Selected Portfolio Companies:

 

 

 

BPSC
Date of Initial SEAF Investment: November 2000
Business: BPSC is in the business of computer systems design services.
Website: www.bpsc.com.pl

 

 

 

Digital City Media (DCM)
Date of Initial SEAF Investment: November 2001
Business: DCM is the largest cable television and broadband provider in Croatia, with market-leading operations in four major cities and several suburbs in Croatia.
Website: www.dcm.hr

 

 

 

EGEEN
Date of Initial SEAF Investment: March 2002
Business: EGEEN is a drug development company with an IT driven platform for clinical trials.
Website: www.egeeninc.com

 

 

 

 

Medifarm
Date of Initial SEAF Investment: July 2001
Exit Date: November 2003
Business: Medifarm is a pharmaceutical distributor and wholesaler in Croatia.
Website: www.medifarm.hr

 

 

 

Artima
Date of Initial SEAF Investment: April 2003
Exit Date: March 2005
Business: Artima is a supermarket chain concentrated in second tier cities (about 50,000 to 200,000 inhabitants) in the western part of Romania.
Website: www.artima.ro

 

 

 

Asper Biotech
Date of Initial SEAF Investment: October 2000
Business: Asper is in the business of biotechnology, specializing in genotyping and resequencing; as well as novel DNA analyses, hardware, and software.
Website: www.asperbio.com

 
 

 

Investment Funds

Central/Eastern European Growth Fund

Headquarters: 

Parnu mnt 142, 6th Floor
Tallinn 11317, Estonia
Tel: (372) 651 2690/2691/2692
Fax: (372) 651 2693

Year Established:

2000

Fund Size:

USD 20,600,000

Investors:

Deutsche Investions- und Entwicklungsgesellschaft (DEG), State Secretariat for Economic Affairs (SECO), International Finance Corporation (IFC), Finnish Fund Industrial Co-operation (FinnFund), Evangelische Kirche, Merifin, SEAF and Calvert

Investment Focus By Stage:

Early stage and expansion of SMEs

Investment Focus by Geography:

Central and Eastern Europe

Investment Size:

USD 500,000-4,000,0000 per Portfolio Company

Director General:

Gary Dodge

Selected Portfolio Companies:

BPSC
Date of Initial SEAF Investment: November 2000
Business: BPSC is in the business of computer systems design services.
Website: www.bpsc.com.pl

Digital City Media (DCM)
Date of Initial SEAF Investment:
November 2001
Business: DCM is the largest cable television and broadband provider in Croatia, with market-leading operations in four major cities and several suburbs in Croatia.
Website: www.dcm.hr

EGEEN
Date of Initial SEAF Investment: March 2002
Business: EGEEN is a drug development company with an IT driven platform for clinical trials.
Website: www.egeeninc.com

Medifarm
Date of Initial SEAF Investment: July 2001
Exit Date: November 2003
Business: Medifarm is a pharmaceutical distributor and wholesaler in Croatia.
Website: www.medifarm.hr

Artima
Date of Initial SEAF Investment: April 2003
Exit Date: March 2005
Business: Artima is a supermarket chain concentrated in second tier cities (about 50,000 to 200,000 inhabitants) in the western part of Romania.
Website: www.artima.ro

Asper Biotech
Date of Initial SEAF Investment: October 2000
Business: Asper is in the business of biotechnology, specializing in genotyping and resequencing; as well as novel DNA analyses, hardware, and software.
Website: www.asperbio.com